当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析

鲁抗医药

(600789)

  

流通市值:53.76亿  总市值:53.76亿
流通股本:8.96亿   总股本:8.96亿

鲁抗医药(600789)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.71亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益381265.80万元,未分配利润93546.46万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产891490.68万元,负债510224.88万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,798,732,648.446,146,721,439.544,731,864,846.813,186,169,198.27
营业总成本1,738,362,575.975,907,664,138.074,571,950,527.783,067,725,236.26
营业利润80,583,215.16272,133,452.46221,180,370.25149,116,053.78
利润总额80,919,131.21272,975,170.25221,838,473.98149,449,588.71
净利润70,966,706.12256,787,289.15199,946,241.92135,726,464.98
其他综合收益--5,149,302.51-3,800,819.55-3,800,819.55
综合收益总额70,966,706.12251,637,986.64196,145,422.37131,925,645.43
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,739,471,654.833,647,794,413.963,457,188,012.333,202,459,212.95
非流动资产合计5,175,435,154.165,154,637,083.915,151,297,482.585,134,926,785
资产总计8,914,906,808.998,802,431,497.878,608,485,494.918,337,385,997.95
流动负债合计3,467,439,679.263,517,330,698.73,082,967,022.363,085,407,905.51
非流动负债合计1,634,809,149.671,543,752,423.351,840,873,856.841,596,536,597.47
负债合计5,102,248,828.935,061,083,122.054,923,840,879.24,681,944,502.98
归属于母公司股东权益合计3,679,345,474.073,611,695,001.533,526,937,521.683,500,781,037.75
股东权益合计3,812,657,980.063,741,348,375.823,684,644,615.713,655,441,494.97
负债和股东权益合计8,914,906,808.998,802,431,497.878,608,485,494.918,337,385,997.95
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,322,433,200.65,545,717,032.853,814,495,258.542,630,939,699.48
经营活动现金流出小计1,159,583,913.344,941,711,3313,353,920,087.552,245,618,164.8
经营活动产生的现金流量净额162,849,287.26604,005,701.85460,575,170.99385,321,534.68
投资活动现金流入小计110,0002,168,695.23119,258.44-
投资活动现金流出小计94,646,998.13371,943,805.73285,913,055.55191,375,056.07
投资活动产生的现金流量净额-94,536,998.13-369,775,110.5-285,793,797.11-191,375,056.07
筹资活动现金流入小计270,121,151.642,248,783,094.11,741,939,494.681,077,334,249.8
筹资活动现金流出小计328,516,673.912,342,706,377.041,889,166,359.31,156,609,523.7
筹资活动产生的现金流量净额-58,395,522.27-93,923,282.94-147,226,864.62-79,275,273.9
汇率变动对现金及现金等价物的影响130,120.262,700,019.761,216,731.871,355,772.68
现金及现金等价物净增加额10,046,887.12143,007,328.1728,771,241.13116,026,977.39
期末现金及现金等价物余额540,092,784.49530,045,897.37415,809,810.33503,065,546.59
TOP↑